The latest updates from Mesoblast’s Phase III trial on rexlemestrocel-L show that the drug provides the highest benefit when used in patients with certain types of chronic heart failure.
If you are not happy with the results below please do another search
50 search results for:
Drugmaker Biohaven Pharmaceutical said on December 6 the company’s intranasal spray to treat migraine showed rapid pain relief and met the main goals in a late-stage study.
Novartis hopes to still play a role in the development of Covid-19 treatments with ongoing research for a pill that could work broadly against coronaviruses, not just the one that causes Covid-19, chief executive Vas Narasimhan told Reuters.
The Omicron variant of the coronavirus has spread to about one-third of U.S. states, but the Delta version remains the majority of COVID-19 infections as cases rise nationwide, U.S. health officials said on December 5.
The Omicron variant of the coronavirus has been found in about 15 U.S. states so far, but the Delta variant remains the majority of COVID-19 cases nationwide, the head of the U.S. Centers for Disease Control and Prevention said on December 5.
Six more U.S. states confirmed infections of the Omicron variant of COVID-19 on December 3, but the Delta strain likely remains a greater threat as winter sets in and Americans gather for the holidays, experts said.
The U.S. Food and Drug Administration approved Merck’s anti-PD-1 therapy Keytruda for the adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma following complete resection. Additionally, the FDA expanded the indication for Keytruda as adjuvant treatment for stage III melanoma following complete resection to include pediatric patients (12 years and older).
Less than three months after Swedish Orphan Biovitrum AB (Sobi) agreed to be acquired by Advent International and GIC Special Investments for nearly $8 billion, the deal fell through after AstraZeneca withheld the company’s 8 percent stake from the buyout offer.
The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus – possibly one that causes the common cold – present in the same infected cells, according to researchers.
The U.S. health regulator added the FDA’s strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in patients 50 and over, the drugmakers said on December 3.